Citations

Showing 10 of 108104 citations.

Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source
Lambrou, Dimitris , Perlepe, Kalliopi, Eskandari, Ashraf , Nannoni, Stefania , Sirimarco, Gaia , Strambo, Davide , Vemmos, Konstantinos , Koroboki, Eleni, Manios, Efstathios , Vemmou, Anastasia, Rodríguez-Campello, Ana , Cuadrado‐Godia, Elisa , Roquer, Jaume , Arnao, Valentina , Paciaroni, Maurizio , Fuentes, Blanca , Araúz, Antonio , Pertierra, Lucía , Schneider, Maia Gómez , Bandini, Fabio , Cano, Beatriz Chavarría , Mohedano, A.M. Iglesias , Gil-Núñez, Antonio , Putaala, Jukka , Karagkiozi, Efstathia , Makaritsis, Konstantinos , Papavasileiou, Vasileios , Ntaios, George , Lip, Gregory Y H , Michel, Patrik , Korompoki, Eleni , Caso, Valeria , Díez‐Tejedor, Exuperio , Rodríguez‐Pardo, Jorge , Ameriso, Sebastian Francisco , Hawkes, Maximiliano A. , Pastor, Á. García , Tatlisumak, Turgut , Barboza, Miguel Angel , Arauz, Antonio

Mayo Clinic

Stroke | December 26, 2018 | Volume: 49 | Issue: 12 | Pages: 2904-2909

10.1161/strokeaha.118.023281 | PMID 30571398 Get It

Background and Purpose— We aimed to assess if renal function can aid in risk stratification for ischemic stroke or transient ischemic attack (TIA) recurrence and death in patients with embolic stroke of undetermined source (ESUS). Methods— We pooled 12 ESUS datasets from Europe and America. Renal function was evaluated using the estimated glomerular filtration rate (eGFR) and analyzed in continuous, binary, and categorical way. Cox-regression analyses assessed if renal function was independently associated with the risk for ischemic stroke/TIA recurrence and death. The Kaplan-Meier product limit method estimated the cumulative probability of ischemic stroke/TIA recurrence and death. Results— In 1530 patients with ESUS followed for 3260 patient-years, there were 237 recurrences (15.9%) and 201 deaths (13.4%), corresponding to 7.3 ischemic stroke/TIA recurrences and 5.6 deaths per 100 patient-years, respectively. Renal function was not associated with the risk for ischemic stroke/TIA recurrence when forced into the final multivariate model, regardless if it was analyzed as continuous (hazard ratio, 1.00; 95% CI, 0.99–1.00 for every 1 mL/min), binary (hazard ratio, 1.27; 95% CI, 0.87–1.73) or categorical covariate (likelihood-ratio test 2.59, P =0.63 for stroke recurrence). The probability of ischemic stroke/TIA recurrence across stages of renal function was 11.9% for eGFR ≥90, 16.6% for eGFR 60–89, 21.7% for eGFR 45–59, 19.2% for eGFR 30–44, and 24.9% for eGFR <30 (likelihood-ratio test 2.59, P =0.63). The results were similar for the outcome of death. Conclusions— The present study is the largest pooled individual patient-level ESUS dataset, and does not provide evidence that renal function can be used to stratify the risk of ischemic stroke/TIA recurrence or death in patients with ESUS.
Validation of the Intracerebral Hemorrhage Score in Uganda
Abdallah, Amir , Chang, Jonathan L. , O’Carroll, Cumara B. , Okello, Samson , Olum, Sam , Acan, Moses, Aden, Abdirahim Abdi, Chow, Felicia C. , Siedner, Mark J. , Mbonde, Amir A.

Mayo Clinic

Stroke | December 26, 2018 | Volume: 49 | Issue: 12 | Pages: 3063-3066

10.1161/strokeaha.118.022057 | PMID 30571425 Get It

Background and Purpose— Rates of intracerebral hemorrhage (ICH) are estimated to be highest globally in sub-Saharan Africa. However, outcomes of ICH are poorly described and standard prognostic markers for ICH have not been validated in the region. Methods— We enrolled consecutive patients with computed tomography-confirmed ICH at a referral hospital in southwestern Uganda. We recorded demographic, clinical, and radiographic features of ICH, and calculated ICH scores. We fit Poisson regression models with robust variance estimation to determine predictors of case fatality at 30 days. Results— We enrolled 73 individuals presenting with computed tomography-confirmed ICH (mean age 60 years, 45% [33/73] female, and 14% [10/73] HIV-positive). The median ICH score was 2 (interquartile range, 1–3; range, 0–5). Case fatality at 30 days was 44% (32/73; 95% CI, 33%–57%). The 30-day case fatality increased with increasing ICH score of 0, 1, and 5 from 17%, 23%, to 100%, respectively. In multivariable-adjusted models, ICH score was associated with case fatality (adjusted relative risk, 1.48; 95% CI, 1.23–1.78), as were HIV infection (adjusted relative risk, 1.92; 95% CI, 1.07–3.43) and female sex (adjusted relative risk, 2.17; 95% CI, 1.32–3.59). The ICH score moderately improved with the addition of a point each for female sex and HIV serostatus (0.81 versus 0.73). Conclusions— ICH score at admission is a strong prognostic indicator of 30-day case fatality in Uganda. Our results support its role in guiding the care of patients presenting with ICH in the region.
Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission
Husseini, Nada El , Sheng, Shubin , Schulte, Phillip J. , Xian, Ying , Goldstein, Larry B. , Fonarow, Gregg C. , Smith, Eric Edward , Ju, Christine , Schwamm, Lee H. , Hernandez, Adrian F.

Mayo Clinic

Stroke | December 26, 2018 | Volume: 49 | Issue: 12 | Pages: 2896-2903

10.1161/strokeaha.118.022011 | PMID 30571413 Get It

Background and Purpose— Kidney dysfunction is common among patients hospitalized for ischemic stroke. Understanding the association of kidney disease with poststroke outcomes is important to properly adjust for case mix in outcome studies, payment models and risk-standardized hospital readmission rates. Methods— In this cohort study of fee-for-service Medicare patients admitted with ischemic stroke to 1579 Get With The Guidelines-Stroke participating hospitals between 2009 and 2014, adjusted multivariable Cox proportional hazards models were used to determine the independent associations of estimated glomerular filtration rate (eGFR) and dialysis status with 30-day and 1-year postdischarge mortality and rehospitalizations. Results— Of 204 652 patients discharged alive (median age [25th–75th percentile] 80 years [73.0–86.0], 57.6% women, 79.8% white), 48.8% had an eGFR ≥60, 26.5% an eGFR 45 to 59, 16.3% an eGFR 30 to 44, 5.1% an eGFR 15 to 29, 0.6% an eGFR <15 without dialysis, and 2.8% were receiving dialysis. Compared with eGFR ≥60, and after adjusting for relevant variables, eGFR <45 was associated with increased 30-day mortality with the risk highest among those with eGFR <15 without dialysis (hazard ratio [HR], 2.09; 95% CI, 1.66–2.63). An eGFR <60 was associated with increased 1-year poststroke mortality that was highest among patients on dialysis (HR, 2.65; 95% CI, 2.49–2.81). Dialysis was also associated with the highest 30-day and 1-year rehospitalization rates (HR, 2.10; 95% CI, 1.95–2.26 and HR, 2.55; 95% CI, 2.44–2.66, respectively) and 30-day and 1-year composite of mortality and rehospitalization (HR, 2.04; 95% CI, 1.90–2.18 and HR, 2.46; 95% CI, 2.36–2.56, respectively). Conclusions— Within the first year after index hospitalization for ischemic stroke, eGFR and dialysis status on admission are associated with poststroke mortality and hospital readmissions. Kidney function should be included in risk-stratification models for poststroke outcomes.
Comparison of recovery and outcome after left and right colectomy
Lovely, Jenna K. , Crippa, Jacopo , Ansell, James , Hübner, Martin , Mathis, Kellie L. , Grass, F , Crippa, J , Hübner, Martin , Grass, Fabian , Larson, David W.

Mayo Clinic

Colorectal Disease | December 26, 2018 | Volume: 21 | Issue: 4 | Pages: 481-486

10.1111/codi.14543 | PMID 30585680 Get It

AbstractAimThe present study aimed to compare functional recovery and surgical outcomes after left and right colectomies.MethodConsecutive elective left and right colon resections for benign and malignant indications, performed between 2011 and 2016 and recorded in a prospectively maintained enhanced recovery database, were analysed. Demographic and surgical items, as well as functional recovery and 30‐day complications, were compared between left‐sided and right‐sided colectomies. Multivariable analysis was performed to identify risk factors for postoperative ileus (POI).ResultsIn total, 1001 left and 1041 right colectomies were comparable regarding demographic factors; only body mass index (BMI) was higher in patients undergoing left‐sided resections (> 30 kg/m2: 33% vs 27%, P = 0.004). Malignancy (29% vs 67%, P < 0.001) and Crohn's disease (1% vs 31%, P < 0.001) were preponderant in right colectomies, whereas diverticular disease (68% vs 1%, P < 0.001) was the most common indication for left colectomy. Compliance with the enhanced recovery pathway (ERP) was comparable. While the minimally invasive approach was the preferred approach for both sides (61% vs 64%, P = 0.158), left colectomies took longer (180 ± 80 min vs 150 ± 70 min, P < 0.001), needed more perioperative fluids (3.1 ± 1.4 l vs 2.7 ± 1.5 l, P < 0.001) and resulted in greater postoperative weight gain (3.9 ± 6.5 kg vs 2.6 ± 6 kg, P = 0.025). Crohn's disease (OR = 2.64, 95% CI: 1.27–5.46) and fluid overload (OR = 2.02, 95% CI: 1.06–3.82) were independent risk factors for POI.ConclusionDespite equal ERP compliance, postoperative ileus was higher after right‐sided colectomies. This finding was associated with Crohn's disease and fluid overload.
Current perspectives in assessing humoral immunity after measles vaccination
Haralambieva, Iana H. , Kennedy, Richard B. , Ovsyannikova, Inna G. , Schaid, Daniel J. , Kennedy, Richard , Poland, Gregory A.

Mayo Clinic

Expert Review of Vaccines | December 26, 2018 | Volume: 18 | Issue: 1 | Pages: 75-87

10.1080/14760584.2019.1559063 | PMID 30585753 Get It

Simultaneous Detection of Dopamine and Serotonin—A Comparative Experimental and Theoretical Study of Neurotransmitter Interactions
Manciu, Felicia , Ciubuc, John, Sundin, Emma , Ochoa, Katia, Eastman, Michael P., Durrer, William, Guerrero, José Antonio Esquivel , Lopez, Brayant, Subedi, Mahendra, Bennet, Kevin E. , Manciu, Felicia S , Manciu, Marian , Guerrero, Jose

Mayo Clinic

Biosensors | December 26, 2018 | Volume: 9 | Issue: 1 | Pages: 3

10.3390/bios9010003 | PMID 30587770 Get It

With the goal of accurately detecting and quantifying the amounts of dopamine (DA) and serotonin (5-HT) in mixtures of these neurotransmitters without using any labelling, we present a detailed, comparative computational and Raman experimental study. Although discrimination between these two analytes is achievable in such mixtures for concentrations in the millimolar range, their accurate quantification remains unattainable. As shown for the first time in this work, the formation of a new composite resulting from their interactions with each other is the main reason for this lack of quantification. While this new hydrogen-bonded complex further complicates potential analyte discrimination and quantification at concentrations characteristic of physiological levels (i.e., nanomolar concentrations), it can also open new avenues for its use in drug delivery and pharmaceutical research. This remark is based not only on chemical interactions analyzed here from both theoretical and experimental approaches, but also on biological relationship, with consideration of both functional and neural proximity perspectives. Thus, this research constitutes an important contribution toward better understanding of neural processes, as well as toward possible future development of label-free biosensors.
A case of Verruconis gallopava infection in a heart transplant recipient successfully treated with posaconazole
Moran, Conor , Delafield, Nathan L., Kenny, Grace , Asbury, Kara , Larsen, Brandon T. , Lambert, Karen L., Patron, Roberto L. , Asbury, Kara L, Delafield, Nathan L.

Mayo Clinic

Transplant Infectious Disease | December 26, 2018 | Volume: 21 | Issue: 2 | Pages: No page available

10.1111/tid.13044 | PMID 30585691 Get It

AbstractVerruconis gallopava is an environmental dematiaceous fungus that is recognized increasingly as a cause of human disease, especially for immunocompromised persons. Infection can range from superficial and localized lesions to pulmonary involvement and disseminated disease, including central nervous system abscesses. Optimal therapy is undefined. We report a patient post cardiac transplant who had pulmonary infection with V gallopava and was treated successfully with posaconazole.
Lead perforation extending beyond the pericardium: Can we treat it percutaneously? Poke, pause, pray, and perform
Sabbag, Avi , Deshmukh, Abhishek , Deshmukh, Abhishek J , Sabbag, Avi

Mayo Clinic

Journal of Cardiovascular Electrophysiology | December 26, 2018 | Volume: 30 | Issue: 3 | Pages: 308-310

10.1111/jce.13837 | PMID 30585675 Get It

AbstractCardiac implantable electronic devices (CIED) are utilized in increasing number and in heterogeneous populations. With excellent training, checklists, and “muscle memory,” the implantation procedure is generally very safe and efficient. Nevertheless, significant and potentially life‐threatening complications can occur.
Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal’s Self-regulatory Model
Westbrook, Travis D., Maddocks, Kami J. , Jones, Jeffrey A. , Woyach, Jennifer A. , Byrd, John C. , Andersen, Barbara L. , Byrd, John C. , Morrison, Eleshia J, Morrison, Eleshia J. P. , Awan, Farrukh T. , Johnson, Amy Jo , Byrd, John C

Mayo Clinic

Annals of Behavioral Medicine | December 26, 2018 | Volume: 53 | Issue: 9 | Pages: 839-848

10.1093/abm/kay093 | PMID 30590383 Get It

Abstract Background Leventhal’s Self-regulatory Model proposes that somatic characteristics of a health threat (e.g., symptom severity), and prior experience with the threat (e.g., unsuccessful treatment), are determinants of illness perceptions. Chronic lymphocytic leukemia (CLL) is appropriate for test of these postulates, having three phases differing in symptom severity and prior treatment experiences: indolent disease requiring no treatment (active surveillance; AS), symptomatic disease requiring a first treatment (FT), and highly symptomatic disease in those who have relapsed and/or failed to respond to prior treatments (relapsed/refractory; RR). Purpose To test symptom severity and prior treatment experiences as determinants of illness perceptions, illness perceptions were characterized and contrasted between CLL groups. Methods Three hundred and thirty CLL patients (AS, n = 100; FT, n = 78; RR, n = 152) provided illness perception data on one occasion during a surveillance visit (AS) or prior to beginning treatment (FT, RR). Results Analysis of variance with planned comparisons revealed that consequences, identity, and concern were least favorable among RR patients, followed by FT, then AS (ps < .01). AS patients endorsed the lowest levels of coherence (ps < .01), and the most chronic illness timeline (ps < .01). FT patients endorsed the highest levels of personal and treatment control (ps < .01). Conclusions Data provide preliminary empirical support for Self-regulatory Model postulates that symptom severity and prior disease experiences influence illness perceptions. Unique knowledge needs for AS patients and elevated psychological/physical symptoms for later-stage CLL patients may warrant clinical attention.
Irreversible Electroporation in Liver Cancers and Whole Organ Engineering
Saini, Aman , Breen, Ilana, Alzubaidi, Sadeer , Sheth, Rahul A. , Naidu, Sailendra , Knuttinen, M. Grace , Albadawi, Hassan , Öklü, Rahmi , Pershad, Yash , Oklu, Rahmi

Mayo Clinic

Journal of Clinical Medicine | December 26, 2018 | Volume: 8 | Issue: 1 | Pages: 22

10.3390/jcm8010022 | PMID 30585195 Get It

Liver cancers contribute significantly to cancer-related mortality worldwide and liver transplants remain the cornerstone of curative treatment for select, early-stage patients. Unfortunately, because of a mismatch between demand and supply of donor organs, liver cancer patients must often wait extended periods of time prior to transplant. A variety of local therapies including surgical resection, transarterial chemoembolization, and thermal ablative methods exist in order to bridge to transplant. In recent years, a number of studies have examined the role of irreversible electroporation (IRE) as a non-thermal local ablative method for liver tumors, particularly for those adjacent to critical structures such as the vasculature, gall bladder, or bile duct. In addition to proving its utility as a local treatment modality, IRE has also demonstrated promise as a technique for donor organ decellularization in the context of whole-organ engineering. Through complete non-thermal removal of living cells, IRE allows for the creation of an acellular extra cellular matrix (ECM) scaffold that could theoretically be recellularized and implanted into a living host. Here, we comprehensively review studies investigating IRE, its role in liver cancer treatment, and its utility in whole organ engineering.